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Hedgehog Signaling Regulates Differentiation
from Double-Negative to Double-Positive
Thymocyte
of zinc finger transcription factors. Three gli genes have
been described in vertebrates, gli-1, -2, and -3. Tran-
scription of both gli-1 and gli-2 genes is upregulated
upon Hh signaling (reviewed by Ruiz i Altaba, 1999).
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(reviewed by Ingham, 1998). Truncated variants of GliSir Alexander Fleming Building
proteins exert positive or negative effects on target geneImperial College Road
transcription (Ruiz i Altaba, 1999). ptc is itself a targetLondon SW7 2AZ
gene of Hh signaling (Goodrich et al., 1996), providing
United Kingdom negative feedback regulation (Goodrich et al., 1999).
²Skin Group The expression of bone morphogenic protein 4 (Bmp-
Ontogeny, Inc. 4), a member of the TGFb family of secreted proteins and
45 Moulton Street a mammalian homolog of Drosophila decapentaplegic
Cambridge, Massachusetts 02138 (dpp), may serve as an indicator of Hh signaling (re-
viewed by Hammerschmidt et al., 1997). Here we show
that Shh, Ptc, Smo, Hedgehog-interacting protein (HIP),
Gli-1, Gli-2, Gli-3, and Bmp-4 are expressed in the thy-Summary
mus and that the Hh signaling pathway regulates T cell
development.The hedgehog (Hh) signaling pathway is involved in
During T cell development, thymocytes pass throughthe development of many tissues. Here we show that
a series of stages, which can be defined in terms of cellsonic hedgehog (Shh) is involved in thymocyte devel-
surface expression of CD4 and CD8. CD42CD82 double-opment. Our data suggest that termination of Hh sig-
negative (DN) thymocytes progress to the CD41CD81
naling is necessary for differentiation from CD42CD82 double-positive (DP) stage and then to mature CD4 or to
double-negative (DN) to CD41CD81 double-positive CD8 single-positive (SP) T cells. The DN population can
(DP) thymocyte. Shh is produced by the thymic stroma, be further subdivided: CD4411CD252 cells acquire CD25
and Patched and Smoothened (Smo), the transmem- expression, lose CD44 expression, and finally become
brane receptors for Shh, are expressed in DN thymo- cycling CD252CD442 DN cells before differentiating to
cytes. A neutralizing monoclonal antibody against Shh DP cells. This sequence of developmental stages can
increases differentiation of DN to DP thymocytes, and be summarized as: CD4411CD252 ! CD4411CD251 !
Shh protein arrests thymocyte differentiation at the CD442CD251 ! CD442CD252DN ! DP ! SP (reviewed
by Haks et al., 1999). Thymocytes may pass throughCD251 DN stage, after T cell receptor b (TCRb) gene
an immature CD81 SP stage before becoming DPrearrangement. We show that one consequence of
cells. These CD81 immature single-positive (ISP) thymo-pre-TCR signaling is downregulation of Smo, allowing
cytes are particularly evident during fetal developmentDN thymocytes to proliferate and differentiate.
where the CD252CD442 DN population may be absent
(Andjelic et al., 1993). Both the CD252CD442 DN pop-
Introduction ulation and the ISP population are proliferating cells
that have been selected for successful T cell receptor
The hedgehog (Hh) family of secreted proteins plays a b (TCRb) rearrangement. The transition from a DN to
major part in many patterning processes during animal DP cell depends on the expression of a functional pre-
development. Hh was first identified in Drosophila, TCR complex (reviewed by von Boehmer et al., 1999).
where its mutations disrupt the polarity of larval seg- This study focuses on the main abTCR T cell lineage
ments (Nusslein-Volhard and Wieschaus, 1980). Three and the transition from a DN to DP cell. At this stage,
mammalian family members have been identifiedÐ the pre-TCR signals for allelic exclusion of the TCRb
sonic (Shh), desert (Dhh), and Indian hedgehog (Ihh) locus, proliferation, and differentiation (reviewed by von
(reviewed by Hammerschmidt et al., 1997). Hh proteins Boehmer et al., 1999), although the downstream trans-
signal to nearby cells through two transmembrane pro- duction pathways that regulate these three outcomes
teinsÐPatched (Ptc) and Smoothened (Smo). of pre-TCR signaling diverge (Gaertner et al., 1999). Fetal
Ptc is thought to be the primary receptor for Hh, but thymus organ culture (FTOC) provides an ideal in vitro
expression of Smo is required for cells to transduce a system to study thymocyte development, as embryonic
hedgehog signal. In the absence of a Hh ligand, Ptc day 14 (E14) fetal thymus does not contain cells that
inhibits the activity of Smo, which in the absence of Ptc have passed beyond the CD251 DN stage, and these
is constitutively active (reviewed by Ingham, 1998). The precursor cells can differentiate in culture through all
binding of the ligand relieves the inhibition (Murone et normal stages of thymocyte development to produce
al., 1999), so that Smo can relay the signal into the target mature functional T cells (reviewed by Jenkinson and
Owen 1990).cell.
At the end of the signaling pathway are the Gli family
Results
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We assessed expression of RNAs encoding Shh, Ihh,k Present address: Department of Cell Biology, Faculty of Biology,
Complutense University, 28040 Madrid, Spain. Dhh, Ptc, Smo, HIP, (Chuang and McMahon, 1999), Gli-1,
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Figure 1. RT-PCR Analysis of Expression of
Components of the Hedgehog Signaling
Pathway in the Thymus
(A) RT-PCR analysis of expression of HPRT
(H), Ihh (I), Shh (S), Ptc (P), Smo (Sm), HIP,
Gli-1 (G1), Gli-2 (G2), Gli-3 (G3), and Bmp-4 in
whole adult thymus and E14.5 fetal thymus.
(B) Expression of Shh, Ptc, and Smo in 1 5
total thymus, 2 5 CD251 DN, 3 5 DP, 4 5
CD4SP, 5 5 CD8SP, 6 5 deoxyguanosine-
treated thymus.
Gli-2, and Gli-3, and Bmp-4 by RT-PCR on RNA prepared Analysis of DN cells showed that the CD4411CD252
from whole adult thymus and E14.5 fetal thymus (Figure was not stained with anti-Smo antibodies (Figure 3B).
1). shh and ihh RNAs were both present (Figure 1A), but This population comprises the earliest thymic precursor
we were unable to detect dhh RNA (data not shown). cells, which are not committed to the T cell lineage
ptc, smo, and hip RNAs were present (Figure 1A). As (Moore and Zlotnik, 1995). Smo expression was highly
Ptc functions as a receptor for Shh and Smo is involved upregulated in the next subset of CD4411CD251 cells.
in Shh signal transduction, their presence suggests that Both the level of expression and the proportion of cells
the Shh signaling pathway operates in the thymus. Like- staining positive then gradually decreased in each sub-
wise, the presence of the transcription factors Gli-1, sequent DN population, so that although the CD251
Gli-2, and Gli-3 and the secreted protein Bmp-4, all of cells stained positively, in the most mature CD252 DN
which are encoded by Shh target genes (reviewed by population staining had greatly reduced. Thus, the DN
Hammerschmidt et al., 1997; Ingham, 1998), suggests thymocytes that would seem likely to respond to Shh
that the Hh signaling pathway is active in both the adult are the CD251 population. These are the DN cells in
thymus and the embryonic thymus. Relative levels of which the rag genes are expressed and in which TCRb
expression of the gli genes observed in adult thymus and gene segments are undergoing rearrangement (re-
embryonic thymus were markedly different, suggesting viewed by von Boehmer et al., 1999).
that their contribution to thymic development differs When we examined Smo expression on E14 thymo-
with the age of the animal (Figure 1A). cytes, the majority of which are CD251 DN cells, we
In order to determine which cell types in the thymus found that about 65% stained strongly with anti-Smo
express the genes involved in the Hh pathway, RT-PCR antibody (Figure 3C). On E17 thymocytes, cell surface
was carried out on sorted populations of thymocytes Smo expression was found on DN and CD81 ISP cells,
(Figure 1B). We were unable to detect shh RNA in any but Smo expression was downregulated in the DP popu-
of the thymocyte populations, but hh was detected in lation (Figure 3D).
primary cultures of thymic stroma, derived from deoxy- The expression of Hh proteins was assayed by immu-
guanosine-treated thymic lobes, which contain largely nofluorescence on frozen sections of adult murine thy-
epithelial cells (Jenkinson and Owen, 1990). smo RNA
mus. In agreement with the RT-PCR and in situ hybrid-was detected in the DN thymocyte population only. ptc
ization data, Shh was detected in epithelial cells, asRNA was detected in DN, DP, and CD8 SP cells.
demonstrated by double staining with anti-cytokeratinTo confirm the developmental expression of Hh path-
antibodies (Figures 3E and 3F). Shh-positive thymic epi-way genes observed by RT-PCR, we performed in situ
thelial cells appeared as isolated cells or small cell clus-hybridization with radioactively labeled probes recog-
ters throughout the thymic parenchyma, and the highestnizing the three Hh genes as well as general Hh targets
frequency of these cells was observed in the outer cor-(Figure 2). On E15, only shh, but not ihh or dhh transcripts
tex (data not shown). On the contrary, no coexpressionare detectable in a uniform pattern throughout the thy-
of Ihh protein and cytokeratin was found (data notmus (Figures 2A and 2B and data not shown). Likewise,
shown). However, in double staining with anti-lamininthe smo signal transducer, the ptc-2 receptor, and the
antibodies, we found that Ihh expression was mainlytranscription factors gli-1 and gli-2 are expressed
restricted to the blood vessels located in the thymicweakly at this stage (Figures 2C±2F). The corresponding
medulla (Figures 3G and 3H). Some of the small corticalsense probes yield no discernible signal. Interestingly,
blood vessels also stained with the anti-Ihh antibodies,ptc-1 expression could not be assessed by this tech-
whereas no staining was seen in the subcapsullary areanique due to strong nonspecific thymic labeling of the
(Figures 3G and 3H).sense probe.
To investigate the pattern of expression of Smo in
thymocyte populations, we carried out three-color flow
A Neutralizing Antibody against Shh Acceleratescytometry using antibodies against CD4, CD8, and Smo
Thymocyte Development in Thymus Explants(Figure 3A). In agreement with the RT-PCR data, most
As Ptc and Smo were both highly expressed on E14of the DN cells stained brightly with the anti-Smo anti-
thymocytes, we tested the effects of inhibition of thebodies. Cell surface expression of Smo was downregu-
lated in the DP and SP populations (Figure 3A). Hh pathway by culturing thymocytes with the anti-Hh
Hedgehog Regulates Early Thymocyte Development
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Figure 2. In Situ Hybridization Analysis of Hh and Hh Target Gene Expression in the Developing Mouse Thymus
Expression of the indicated genes was investigated in parasagittal paraffin sections of mouse embryos on E15. Bright-field and corresponding
dark-field images were superimposed.
(A and B) Shh, but not Ihh is expressed in the early mouse thymus (t). Note the absence of Ihh signal in the thymus in (B). The same section
displays strong expression of the gene in the cartilage of the developing ribs.
(C±F) Transcripts of Hh target genes are detectable throughout the early mouse thymus. Scale bars denote 100 mm.
neutralizing mAb 5E1 (Ericson et al., 1996). E14 thymus see Figure 4A) had incorporated BrdU, whereas only
22% of CD81 cells did so in the cultures treated withlobes were cultured in the presence of 5 mg/ml of the
purified antibody. After 3 days in culture, we found a anti-Shh antibody (Figure 4D). Thus, the increase in DP
cells could not be accounted for by a simple increaselarge increase in the production of DP thymocytes in
the antibody-treated cultures compared to control cul- in their rate of proliferation, but may be due to an in-
crease in differentiation from DN to DP thymocytes. Thetures. In the presence of the antibody, 58% of cells
progressed to the DP stage, whereas only about 9% of finding that the antibody-treated cultures contained a
smaller proportion of cycling DP cells than the controlthymocytes did so in the control cultures, and the major-
ity of the DN cells in the control cultures still expressed cultures supports the idea that the antibody treatment
had accelerated differentiation and that the DP cells,CD25 (Figure 4A). Thus, neutralization of Shh greatly
increased thymocyte differentiation over this 3 day time after undergoing an initial phase of proliferation, had
progressed to the more mature small nonproliferatingperiod.
In addition, in all experiments, there was a 2- to 3.5- stage. In absolute terms, however, there were more
BrdU1 cells in the antibody-treated cultures than in con-fold increase in the number of thymocytes recovered
from the cultures containing the neutralizing antibody trol cultures.
(Figure 4C); so that, in absolute terms, between 10 and
20 times more DP cells were produced in the antibody-
treated cultures than in control cultures. Shh Protein Arrests Thymocyte Development
at the DN StageAs the neutralizing antibody increased the production
of DP thymocytes, it seemed possible that DN thymo- Given that the anti-Shh antibody increased the differen-
tiation of DN to DP thymocytes, we tested the effect ofcytes were being induced to differentiate before they
had rearranged a TCRb chain gene. We therefore exam- Shh protein on thymocyte development. Human recom-
binant Shh modified for high activity was added to theined the expression of the abTCR on the DP thymocytes
from the control and anti-Shh-treated cultures. Levels cultures at concentrations ranging from 0.1 mg/ml to 1.8
mg/ml. After 2 days, the culture medium was changedof expression of the TCRb chain were very similar in
both culture conditions, suggesting that the extra DP and fresh Shh was added. After 5 days, about 30% of
thymocytes in control cultures expressed CD4 and CD8,thymocytes produced in the presence of the anti-Shh
antibody had rearranged their TCRb gene (Figure 4B). whereas in the presence of Shh the production of DP
thymocytes was inhibited in a dose-dependent manner,In addition, we looked at expression of CD2 and CD24
(HSA) on the DP cells and found no differences (Fig- with maximum inhibition at 0.9 mg/ml (Figure 4E). Thus,
Shh arrested thymocyte development at the DN stage.ure 4B).
One explanation for the increase in DP cells in anti- These concentrations of Shh are within the predicted
physiological range, as this modified Shh protein hasbody-treated cultures is that neutralization of Shh stimu-
lated proliferation of DP cells, rather than increasing the maximum activity in a cell-based reporter gene assay
at 0.3 mg/ml and is thought to be about 20±30 timesdifferentiation of DN cells. To test this, we added BrdU
to 3 day cultures of thymus overnight and assessed more active than the unmodified Shh protein (J. Porter,
personal communication). Analysis of the compositionBrdU incorporation into CD81 cells by flow cytometry
using antibodies against BrdU and CD8. In the control of the DN cells showed an increase in the proportion of
CD251CD44dull DN cells and a concomitant decrease incultures, 40% of CD81 cells (made up mostly of DP cells;
Immunity
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Figure 3. Expression of Smo and Hh Proteins
in the Murine Thymus
(A±D) Adult thymocytes (A), purified adult DN
cells (B), E14 (C), and E17 thymocytes (D)
were stained for three-color flow cytometry.
Dot plots show CD4 versus CD8 expression
on adult (A) and embryonic (C and D) thymo-
cytes and CD44 versus CD25 expression on
DN cells (B). Histograms show the expression
of Smo (thick lines) in each of the gated cell
populations shown in the dot plots. Thin lines
represent background fluorescence using ir-
relevant antibodies.
(E±H) Frozen sections of murine thymus were
double stained with anti-Shh (E) and anti-
cytokeratin (F) or anti-Ihh (G) and anti-laminin
(H). Shh protein is detected in cytokeratin-
positive epithelial cells (arrows), appearing in
the thymic cortex. Ihh expression is restricted
to blood vessels (revealed with anti-laminin
antibodies, arrows), mainly from the thymic
medullary region (M). C, cortex; Sc, subcap-
sullary area. Scale bars: 10 mm (E and F), 100
mm (G and H).
the proportion of CD252CD442 DN cells compared to Shh Does Not Induce Cell Death of Thymocytes
DP thymocytes express Ptc (Figure 1B), and so theycontrol cultures (Figure 4F). The number of thymocytes
recovered from cultures treated with 0.9 mg/ml Shh was may bind Shh at the cell surface. Although they seem
unlikely to transmit a Hh signal, as they no longer ex-about one-half of that recovered from control cultures
(Figure 4C). press Smo, one possible explanation for the absence
of DP cells in the explants cultured with Shh is that ShhAs neutralizing anti-Shh antibody and Shh protein had
opposite effects on thymocyte development, it seemed induces apoptosis in the DP population. To test this, we
incubated E14.5 and E17.5 thymus explants with Shhunlikely that the arrest in differentiation caused by Shh
was the result of nonspecific toxicity or that the increase or anti-Shh and monitored cell death in the cultures by
Annexin-V staining of DN and DP populations. Therein DP cells induced by anti-Shh treatment was due to
a nonspecific action of the antibody. To confirm this, was no difference in cell death of DN or DP cells in all
explants, whether cultured with or without Shh or anti-we added both Shh and anti-Shh antibody (Figure
5A). Addition of 0.9 mg/ml Shh and 5 mg/ml anti-Shh Shh (data not shown).
Since apoptotic DP cells disappear rapidly from thy-increased both the proportion of DP thymocytes and
the total cell numbers relative to the control (Figures 4C mus explants, we also measured the effect of Shh on
sorted DP thymocytes in suspension. After 24 hr andand 5A). The ability of the antibody to overcome the
action of 0.9 mg/ml of Shh was dose dependent (Fig- 48 hr, there was no difference in cell death, cell cycle
status, or differentiation of DP cells with or without Shhure 4C).
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Figure 4. Shh Neutralization Stimulates Thymocyte Differentiation, and Shh Arrests Thymocyte Differentiation
(A) E 14 FTOC in the presence of neutralizing anti-Hh mAb (5 mg/ml) for 3 days. Cells were stained for three-color flow cytometry. Expression
of CD4, CD8, and CD25 are shown. Viable cells per lobe (31024) were: control 2.9, anti-Shh 9.8.
(B) Phenotype of DP thymocytes after 3 days with or without anti-Shh mabs. Cells were analyzed by three-color flow cytometry. Histograms
show TcRab, CD24, and CD2 staining on DP cells.
(C) Effect of Shh and anti-Shh treatments on cell yield of FTOC. Data from individual experiments are represented as a function of the number
of cells in control cultures (number of cells/number of cells in control FTOC).
(D) BrdU expression in CD81 cells from control and anti-Shh-treated FTOC. BrdU was added during the last 16 hr of culture. Thymocytes
were stained for CD8, CD25, and BrdU. BrdU expression gated on the CD81 cell population is shown (thin lines), and the percentage of BrdU-
positive cells is indicated in each histogram. Thick lines represent the staining with isotype-matched control antibodies.
(E) Flow cytometry analysis of E14 FTOC cultured in the presence of different doses of Shh for 5 days. Viable cells per lobe (31025) after 5
days of culture were: control 2.2; 0.1 mg/ml Shh 2.6; 0.3 mg/ml Shh 1.8; 0.9 mg/ml Shh 1.1; 1.8 mg/ml Shh 1.2.
(F) Phenotype of DN cells from control and Shh-treated (0.9 mg/ml) FTOC. Cells recovered from the thymic lobes after 5 days of culture were
triple labeled with anti-CD44Cychrome, anti- CD25PE, anti-CD4FITC, and anti-CD8FITC. The expression of CD44 and CD25 was analyzed on DN cells
by gating cells stained negative with both anti-CD4 and anti-CD8.
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Figure 5. Anti-Shh and Shh Neutralize One
Another in Thymus Explants, and Shh Affects
TCRgd1 Cells but Does Not Affect DP Thymo-
cytes
(A) Neutralization of the inhibitory effect of
Shh with neutralizing anti-Shh mAb. E14
mouse FTOC cultured in the absence or the
presence of Shh (0.9 mg/ml) and anti-Shh
mAb (5 mg/ml) for 3 days and analyzed for
CD4 and CD8 expression. Viable cells per
lobe (31024) were: control 3.1; anti-Shh 6.5;
Shh 1.5; anti-Shh 1 Shh 4.8.
(B) Effect of 5 days of Shh treatment on gd
and CD42CD82ab1 cell lineages. The number
of thymocytes was calculated after flow cyto-
metric analysis using antibodies against CD4,
CD8, TCRb, and TCRgd and is expressed as
the percentage of values from the control
FTOC (number of cells 3 100/number of cells
in control FTOC).
(C) Incubation with Shh has no effect on dif-
ferentiation, death, or proliferation of sorted
DP thymocytes. Sorted DP thymocytes were
incubated with or without Shh (0.9 mg/ml) and
analyzed by flow cytometry after 24 hr and
48 hr. Cells were stained with CD4 and CD8
(top panel) and Annexin-V (bottom panel), and
permeabilized cells were stained with Propid-
ium Iodide (PI, middle panel).
(Figure 5C). These data suggest that the effect of Shh germline fragment with the rearranged Db to Jb seg-
ments that appear as a ladder below the germline bandobserved in thymus explants was due to a Shh-induced
block in differentiation of DN cells, rather than to an (Gaertner et al., 1999). Levels of rearrangement were
comparable in all cultures (Figure 6A), showing that Shheffect of Shh on the emerging DP population. It is possi-
ble that Ptc expression on DP cells functions to seques- arrests thymocyte development after initiation of TCRb
rearrangement.ter Hh from the DN population, modulating local Hh
concentrations in the thymus.
Shh Upregulates Smoothened in DN Thymocytes
Shh has been shown to upregulate its receptor (Ptc)Shh Reduced the Production of TCRgd1 Thymocytes
The addition of Shh reduced the numbers of TCRgd1 thy- in many cell types, and a high level of Ptc expression
provides further indication of active Hh signaling (Good-mocytes in thymus explants (Figure 5B). CD81TCRgd1
thymocytes were affected more than CD42CD82TCRgd1 rich et al., 1996). We examined the expression of Smo
in FTOC after 5 days in culture with 0.9 mg/ml Shh.thymocytes. In contrast, the subset of CD42CD82TCRab1
thymocytes was hardly reduced after Shh treatment Shh upregulated Smo (Figure 6B). This upregulation was
evident in the DN population, since few thymocytes dif-(Figure 5B). The inhibition of production of TCRgd1
thymocytes is consistent with the fact that the TCRgd1 ferentiated beyond this stage.
and the main population of TCRab1 lymphocytes
share a common CD251 precursor (reviewed by Kang Shh Regulates Proliferation of CD251 DN Thymocytes
and Raulet, 1997), whereas the DNTCRab1 population Productive TCRb gene rearrangement (and hence pre-
represent a distinct lineage (reviewed by Bendelac et TCR signaling) in CD251 DN thymocytes has been
al., 1997). shown to stimulate cell cycle progression (Hoffman et
al., 1996), as well as differentiation from DN to DP cell
(reviewed by von Boehmer et al., 1999). Since Hh signal-Shh Arrests DN Thymocytes after Initiation
of TCRb Gene Rearrangement ing in the developing thymus seems to oppose the in-
duction of differentiation by the pre-TCR, we asked ifIn order to ask if Shh arrests thymocyte development
before TCRb rearrangement, we used PCR to amplify neutralization of Hh signaling could alter cell cycle pro-
gression in CD251 DN thymocytes. BrdU incorporationgenomic DNA segments from sorted DN cells from E14.5
thymus explants cultured for 5 days with or without Shh was measured in CD251 DN cells on day 4 of culture.
Following overnight incubation with BrdU, cells wereusing primers upstream of Db2 and downstream of Jb2.
This assay enabled us to compare levels of the larger stained with antibodies against CD8, CD25, and BrdU.
Hedgehog Regulates Early Thymocyte Development
193
Figure 6. The Effect of Shh or Ant-Shh Treat-
ment on TCRb Gene Rearrangement, Smo
Expression, Cell Cycle Progression, and the
Differentiation of Rag12/2 Thymus Explants
(A) Shh arrests thymocyte development after
the initiation of TCRb gene rearrangement.
Db to Jb rearrangements were analyzed in
genomic DNA by PCR. DNA was prepared
from wild-type thymus (W), Rag12/2 thymus
(R), and from sorted DN thymocytes from
FTOC cultured for 5 days with or without Shh
(E14.5 1/2). The arrow shows the unre-
arranged genomic product, and the re-
arranged products are seen as bands below.
(B) Flow cytometric analysis of Smo expres-
sion on thymocytes recovered from thymic
lobes after 5 days of culture with or without
Shh (0.9 mg/ml). Smo expression is shown
for the different thymocyte subsets defined
according to CD4 and CD8 expression.
(C) E14 FTOC in the presence of neutralizing
anti-Shh antibodies (5 mg/ml) for 3 days, BrdU
being added for the last 16 hr of the culture
period. Thymocytes recovered from control
and anti-Shh-treated FTOC were stained with
anti-CD8, CD25, and BrdU antibodies and an-
alyzed by three-color flow cytometry. Thin
lines represent BrdU expression on gated
CD82CD251 cell subset, and thick lines rep-
resent the staining with isotype-matched
control antibodies.
(D) Neonatal Rag12/2 thymus explants cul-
tured with anti-CD3 mAb (1.5 mg/ml) or anti-
Shh antibodies (5 mg/ml). After 5 days, thymo-
cytes were stained against CD4 and CD8 and
analyzed by flow cytometry.
(E) Neonatal thymus organ cultures from
Rag12/2 mice were treated with anti-CD3 anti-
bodies (1.5 mg/ml) for 24 hr, washed, and
placed onto new filters with or without anti-
Shh antibodies for 4 days. Cells were stained
for CD4 and CD8 and analyzed by flow cytom-
etry (shown in dot blots). Histograms repre-
sent the cell size of the total thymocyte popu-
lation recovered from both culture conditions.
The proportion of CD251CD82 cells that had incorpo- cannot replace a pre-TCR signal. This is consistent with
the observation that the DP cells produced by the accel-rated BrdU during the incubation increased in the anti-
body treated cultures to 30% compared to only 18% in erated differentiation induced by anti-Shh antibody in
wild-type thymus expressed normal levels of TCRbthe control cultures (Figure 6C). Thus, neutralization of
Hh signaling in CD251 DN cells seems to release them chain and that the differentiation induced by the anti-
body therefore occurred after a pre-TCR signal.from the cell cycle block that occurs during TCRb chain
gene rearrangement. When, however, we treated the Rag12/2 thymus with
anti-CD3 for 24 hr only and then moved the thymus to
fresh medium, with or without anti-Shh (Figure 7B), theAnti-Shh Cooperates with Anti-CD3 to Induce
anti-Shh antibody treatment enhanced thymocyte differ-Differentiation in Rag12/2 Thymus
entiation. The proportion of DP cells produced duringRag12/2 thymocytes are arrested at the CD251 DN stage
the 5 days post CD3 treatment increased from aboutof development (Mombaerts et al., 1992) because they
18% to 31%. This increased differentiation was reflectedcannot rearrange their TCRb chain genes and therefore
in the size of cells, as the thymus treated with bothcannot express the pre-TCR complex. This develop-
anti-Shh and anti-CD3 antibodies contained a greatermental arrest can be overcome by stimulation with anti-
proportion of small cells (Figure 7B), corresponding tobodies against CD3 (Levelt et al., 1993), presumably
more mature small resting DP cells.mimicking the physiological signal that a CD251 DN
thymocyte would receive through its pre-TCR complex.
Since anti-Shh increased differentiation to DP cell in
wild-type cultures (Figure 4A), we asked if anti-Shh treat- Ligation of CD3 on Rag12/2 Thymocytes
Downregulates Smoment could overcome the developmental arrest in
Rag12/2 thymus explants (Figure 7A). The anti-Shh anti- We assessed the effect of signaling through the pre-
TCR on Smo expression. E16 Rag12/2 thymus explantsbody was unable to induce differentiation of DN to DP
cells (Figure 7A), suggesting that neutralization of Shh were cultured in the presence of anti-CD3 mAb for 44
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Figure 7. Shh Modulates Pre-TCR-Delivered
Signals, and Pre-TCR Signaling Downregu-
lates Smo
(A) Pre-TCR signaling downregulates smo
RNA. E16 Rag12/2 thymus explants were cul-
tured for 44 hr in the presence of 5 mg/ml
anti-CD3 mAb. After isolation of RNA and syn-
thesis of cDNA, semiquantitiative RT-PCR
was carried out by removing PCR aliquots at
20, 25, 30, and 35 cycles. The reaction volume
used in each experiment was standardized
according to HPRT expression and resolved
on a 2% agarose gel. Expression of smo RNA
was quantified using the Kodak electrophore-
sis analysis system.
(B) Phenotype of Rag12/2 thymus explants
from which RNA was prepared for the experi-
ment shown in (A). Cells were stained for
CD25 and CD8 expression and analyzed by
flow cytometry.
(C) Differentiating Rag12/2 thymocytes be-
come refractory to Shh signaling within 44 hr
of CD3 ligation. E16 Rag12/2 thymus explants
were incubated with anti-CD3 (5 mg/ml) for
18 hr, washed for 2 hr in medium prior to
addition of anti-Shh (5 mg/ml) or Shh (0.9 mg/
ml) at 20 h,r 44 hr, or 68 hr after the start
of the experiment. At 7 days, explants were
analyzed by flow cytometry using antibodies
against CD4, CD8, and CD25. Dot plots show
CD25 and CD8 staining. DP cells had not yet
appeared.
(D) Proposed model for the function of Hh
signaling in thymocyte development.
hr prior to isolation of RNA and synthesis of cDNA. Semi- CD3 ligation on Rag12/2 thymocytes suggests a direct
link between pre-TCR signaling and the Hh signalingquantitative RT-PCR was carried out by removing PCR
aliquots at 20, 25, 30, and 35 cycles. The reaction volume pathway in the control of differentiation from DN to DP
thymocyte.used in each experiment was standardized according
to HPRT expression. Products were resolved on a 2%
agarose gel (Figure 7A). Quantification of expression
of smo RNA using the Kodak electrophoresis analysis Differentiating Rag12/2 Thymocytes Become
Refractory to Shh Signaling within 44 Hrsystem revealed that following anti-CD3 treatment, ex-
pression of smo RNA was downregulated by 50% in of CD3 Ligation
To test if the observed downregulation of smo RNA atRag12/2 thymus explants. As cells from these explants
were not sorted prior to isolation of RNA, the extent of 44 hr after CD3 ligation was sufficient to render the
differentiating thymocytes refractory to Shh signaling,smo RNA downregulation in the DN population may have
been masked by the presence of smo RNA from the we performed the following experiment. E16 thymus
explants were incubated for 18 hr with anti-CD3 anti-thymic rudiment.
The downregulation of smo RNA preceded differentia- body. Explants were then washed for 2 hr and cultured
in fresh medium. Shh or anti-Shh were added to thetion to DP cell, as after 44 hr anti-CD3 treatment, cell
surface CD25 expression had decreased greatly, but cultures at 20 hr, 44 hr, and 68 hr after initiation of CD3
ligation. Cultures were analyzed by flow cytometry aftercell surface CD8 expression was still undetectable (Fig-
ure 7B). Downregulation of cell surface Smo expression 7 days. Control explants that had received only the 18
hr anti-CD3 treatment had differentiated. About 11%was confirmed by flow cytometry using anti-Smo anti-
bodies (data not shown). That both smo RNA and cell expressed CD8, and about 25% of DN cells had down-
regulated CD25 (Figure 7C). The cultures that weresurface Smo expression are downregulated following
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treated with Shh immediately after anti-CD3 treatment Howrey, G. Hoyne, and J. Lamb, personal communi-
cation).(at 20 hr) contained fewer CD81 cells (5%), whereas
Inhibition of Shh signaling with the neutralizing anti-the cultures that were treated with anti-Shh at 20 hr
Shh antibody cannot replace anti-CD3 signaling incontained a greater proportion CD81 cells (16%) and a
Rag12/2 thymus explants, suggesting that removal oflower proportion of CD251 cells (44% relative to 61%
Shh cannot replace the physiological pre-TCR signal.in the control cultures and 68% in the Shh-treated cul-
The antibody did, however, enhance differentiation intures). Thus, when added 20 hr after initiation of anti-
the Rag12/2 thymus after anti-CD3 stimulation had beenCD3 induced differentiation, Shh inhibited differentiation
removed, and conversely Shh inhibited this differentia-of Rag12/2 thymocytes and anti-Shh treatment en-
tion. It seems that inhibition of Shh signaling can onlyhanced differentiation. When reagents were added 44
promote thymocyte development after a signal throughhr and 68 hr after CD3 ligation, we found that anti-Shh
the pre-TCR complex. Smo is downregulated on CD252had not enhanced differentiation and that Shh had not
DN thymocytes, the proliferating intermediate popula-inhibited differentiation. These data indicate that devel-
tion between CD251 and DP cells, but Ptc expressionoping DN thymocytes become refractive to Hh signaling
remains relatively high on these cells. Taken together,within 2 days of receiving a pre-TCR signal and that
these data are consistent with the following model, illus-Smo downregulation and cessation of Shh signaling is
trated in Figure 7.an early consequence of pre-TCR signaling, which oc-
Shh might function to maintain CD251 DN cells ascurs before the production of DP cells.
nonproliferating cells, while they rearrange their TCRb
genes. During this rearrangement, CD251 DN cells doDiscussion
not proliferate (Hoffman et al., 1996), and reentry into
the cell cycle has been suggested to be one mechanism
Here we show that Shh and the molecules that transduce of maintaining allelic exclusion of the TCRb chain locus
its signal are expressed in the immune system. Our data (Lin and Desiderio, 1995). Cdc2 kinase produced during
suggest that Hh signaling regulates thymocyte devel- cell cycle progression has been shown to target Rag2
opment. protein for degradation (Lin and Desiderio, 1993), pre-
T cell development in the thymus depends on interac- venting further rearrangement once DN cells have
tions between the thymic epithelium and developing started to proliferate again (Hoffman et al., 1996).
thymocytes (Boyd et al., 1993). Our study indicates that We show that an immediate consequence of pre-TCR
one way in which the epithelium regulates the produc- signaling in Rag12/2 thymus explants is downregulation
tion of thymocytes is by the secretion of Shh and the of Smo. Our model proposes that, as Shh can no longer
consequent activation of the Hh signaling pathway in signal after Smo downregulation, the DN cell is released
DN thymocytes. to proliferate and differentiate. High Ptc expression in
Treatment of thymus explants with anti-Shh antibody the CD252 DN and DP populations could sequester Shh
increases differentiation from DN to DP thymocytes, and without transmitting a signal (Chen and Struhl, 1996),
treatment with Shh protein inhibits this differentiation. providing a possible mechanism by which the number
Shh has been shown to inhibit development of the pan- of cells progressing to the DP stage could modulate Shh
creas (Apelsqvist et al., 1997; Hebrok et al., 1998), al- concentrations in the thymus, thus creating a feedback
though in many tissues it promotes cell proliferation loop in thymus homeostasis.
and/or differentiation (reviewed by Hammerschmidt et In summary, we show that the Hh signaling pathway
al., 1997). Our experiments show that Shh treatment of is active during early thymocyte development. Shh is
thymus explants arrests thymocytes as CD251 DN cells, produced by the thymic epithelium, and its receptor
after initiation of TCRb gene rearrangement. Thymo- molecules Ptc and Smo are expressed by DN thymo-
cytes from genetically modified mice that are unable to cytes. In thymus explants, anti-Shh antibody can in-
produce a fully functional pre-TCR complex also fully crease differentiation from DN to DP cell and Shh can
or partially accumulate at this CD251 stage (reviewed arrest thymocyte development at the DN stage. Thus,
by Haks et al., 1999; von Boehmer et al., 1999) implicat- termination of Hh signaling seems to be necessary for
ing Hh signaling in events downstream of a pre-TCR- differentiation from DN to DP cells. Our data indicate
mediated signal. that Hh signaling upregulates Smo in DN thymocytes
We show by RT-PCR and immunohistochemistry that but that, conversely, pre-TCR signaling downregulates
both Shh and Ihh are expressed in the murine thymus, Smo expression in DN cells, suggesting a direct link
and, as the anti-Shh mAb reacts with Ihh and Shh (Vort- between the pre-TCR and Hh signaling pathways. To-
kamp et al., 1996), it is possible that some of the effects gether these findings suggest that Hh signaling plays
observed on treatment of thymus explants with anti-Hh an important part in thymocyte development, regulating
mAb are due to neutralization of Ihh. There are several the progression from DN to DP cell, and modulating
pieces of evidence that suggest that it is Shh that influ- pre-TCR signaling. In the future, it will be interesting to
ences thymocyte development. First, the level of Ihh assess this proposed function of Shh as a regulator of
was below detection by in situ hybridization, whereas the transition from DN to DP thymocyte using more
Shh was detectable in the thymus and Ihh was readily rigourous genetic models.
detectable in neighboring tissues. Second, Shh was ex-
Experimental Procedurespressed by epithelial cells throughout the parenchyma,
and the highest frequency of these cells was observed
Micein the outer cortex, where the immature DN thymocytes
BALB/c mice were purchased from B & K Universal Ltd. (UK) andthat express Smo and Ptc are located. Double staining
maintained in the Central Biomedical Services Unit at Imperial Col-
with anti-laminin and anti-Ihh antibodies localized Ihh lege, London. Rag12/2 mice (Mombaerts et al., 1992), purchased
to blood vessels, largely in the thymic medulla. Third, from Jackson Labs, were maintained in individually ventilated cages.
the thymus of Ihh2/2 mice contains all thymocyte subsets Timed matings were carried out as described previously (Crompton
et al., 1996). Adult mice were 6±10 weeks old.and shows no obvious skewing in cell populations (J.
Immunity
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Flow Cytometry and Antibodies streptavidin (Amersham), and FITC-conjugated anti-cytokeratin
(Sigma), or anti-laminin (Sigma) followed by FITC-conjugated mouseThe neutralizing mAb 5E1 (directed against Shh) developed by Drs.
Johan Ericson and Thomas Jessell (Ericson et al., 1996) was ob- adsorbed F(ab')2 fragment of donkey anti-rabbit IgG (Jackson Im-
munoResearch Laboratories). Slides were mounted in Vectashieldtained from the Developmental Studies Hybridoma Bank, developed
under the auspices of the NICHD, and maintained by the University (Vector Laboratories) and examined on a Zeiss Axioplan-2 micro-
scope.of Iowa, Department of Biological Sciences (Iowa City, IA).
The anti-CD3 mAb 2C11 was purchased from Pharmingen, and
used at a concentration of 1.5 mg/ml (Figures 7A and 7B) or 5 mg/
FTOCml (Figures 7C±7E) in FTOC.
Fetal thymi were dissected on E14 and cultured on Millipore filtersCell suspensions of thymocytes were prepared by crushing the
(8 mm pore size) in AIM-V serum-free lymphocyte medium (Life Tech-thymus between two pieces of ground glass. Cells were stained as
nologies). For the Rag12/2 experiments in Figures 6D and 6E, neona-described previously (Crompton et al., 1996) using combinations of
tal lobes were cultured; whereas, for the experiments in Figuresthe following directly conjugated antibodies purchased from Phar-
7A±7C, E16 lobes were used. FTOC were cultured with or withoutmingen: anti-CD4PE, anti-CD25PE, anti-CD25FITC, anti-CD44Cychrome,
5E1 or modified human Shh. The Shh was the kind gift of Ontogeny,anti-TCRabPE, anti-TCRgdPE, anti-CD2PE, anti-CD3Cychrome, anti-CD24PE
Inc. This Shh was octylated for high activity. As previously describedand the following monoclonal antibodies purchased from Caltag:
(Pepinsky et al., 1998), in vitro modification of N-shh (amino acidsanti-CD8aFITC, anti-CD8aTRICOLOR, anti-CD4TRICOLOR and analyzed on a
25±199) with a lipophilic group on the amino-terminal cysteine signif-Facscan (Becton Dickinson). Data are representative of at least four
icantly increases the specific activity (.30-fold) of E. coli±derivedexperiments.
N-shh as measured by activation of Hh signal transduction in cul-Anti-Smo goat polyclonal antibodies directed against N-terminal
tured cells. Octyl N-shh is a hydrophobically modified version of thepeptides of Smo were purchased from Santa Cruz Biotechnology.
Shh signaling protein generated by coupling N-octyl-maleimide to106 cells from single-cell suspensions were incubated for 30 min in
the amino-terminal cysteine of bacterially derived N-shh. This modi-PBS with 1.5% donkey serum (Santa Cruz Biotechnology) and
fication represents a simple and efficient way to generate high spe-washed with PBS. To block Fc receptor, cells were incubated with
cific activity Shh protein from bacterially expressed Shh (J. Porter,0.5 mg anti-CD16/CD32 (Pharmingen) in 50 ml PBS for 5 min. The
personal communication). This Shh is in a solvent containing 5 mMcells were incubated with anti-Smo antibodies (2 mg in 50 ml PBS)
Na/phosphate buffer (pH 5.5), 150 mM NaCl, and 0.5 mM DTT.in the presence of Fc blocking for 60 min. After washing with PBS
Addition of solvent alone to FTOC did not inhibit thymocyte devel-and 0.5% BSA (Sigma), cells were incubated for 30 min with FITC-
opment.conjugated F(ab')2 fragment of donkey anti-goat IgG (Jackson Labo- Thymic stroma was prepared by culturing E14.5 thymus for 6ratories) in PBS and 1.5% donkey serum. Cells were washed in
days with 0.36 mg/ml 2'4'deoxyguoanosine (Sigma). This procedurePBS and 0.5% BSA prior to incubation with directly conjugated
depletes FTOC of thymocytes but allows epithelium to grow (Jenkin-antibodies as above.
son and Owen, 1990).For the experiments in Figures 1B, 5B, and 6A, purified popula-
tions of thymocytes were sorted by flow cytometry on an ALTRA
(Coulter). For SP and DN populations, cells were partially purified Reverse Transcribed Polymerase Chain Reaction
by magnetic sorting using VarioMacs (Miltenyi Biotec) in conjunction RT-PCR was as described previously (Crompton et al., 1997). Prim-
with Macs colloidal super-paramagnetic MicroBeads conjugated to ers were purchased from Life Technologies or Genosys Biotechnol-
rat anti-mouse CD8a mAb or to rat anti-mouse CD4 mAb (Miltenyi ogies, Ltd. The following primer pairs were used: hprt forward
Biotec). Cells were restained and sorted by flow cytometry. Final TCGTGATTAGCGATGATGAACC, reverse CTGGCAACATCAACAG
purity was in excess of 98%, assessed by Facscan. GACTCC; shh forward ATGTCAGTGTCATCCGAGTGGC, reverse
For BrdU incorporation, BrdU (Boehringer Mannheim) was added TGAATACCACCACCACAGCAGC; ihh forward TCCTATGCTCCTCT
at the manufacturer's recommended concentration. After incubation CACAAGGC, reverse CAGTGGTTAGAGTCCCTTCAGC; dhh forward
with BrdU, cell suspensions were stained with CD8aTRICOLOR and TACCCAACTACAACCCCG, reverse ATGTAGTTCCCTCAGCCC; ptc
CD25FITC as described above. After washing, cells were fixed for 10 forward ATCGGAGTGGAGTTCACC, reverse CTGCTGTGCTTCGT
min in 4% paraformaldehyde (Sigma) in PBS at room temperature. ATTGCC; smo forward CATCAAGTTCAACAGTTCAGGC, reverse
Cells were washed in PBS and incubated for 20 min in ice-cold 70% ATAGGTGAGGACCACGAACCACACTACTCC; hip forward ACTCTC
ethanol. Cells were washed in PBS and incubated for 20 min at TTCTCCTCTCCTTCC, reverse TAGAAGCCACCACACAGG; gli-1
room temperature in 2 M HCl, 0.5%BSA. After washing with PBS, forward CTACGGAACCAACAGTGAGTGG, reverse CGGCACTCA
cells were incubated for 2 min in 0.1 M Na borate solution (pH TAGGCTTCATACC; gli-2 forward GTAGTCTCCTCAGTTACTTGC,
8.5). Cells were washed in PBS and incubated with anti-BrdUPE reverse ATCAATGCCTTCAACCTTCCGC; gli-3 forward CAGAGG
(Pharmingen) or with a preconjugated isotype-matched control ACTTGGACTTAGCAGG, reverse TGCCATTCACTGTGTTGCCAGC;
(Pharmingen, reagent set). These antibodies were used at the manu- bmp-4 forward GAAGAATAAGAACTGCCGTCGC, reverse CACCTT
facturer's recommended concentrations in 40 mM Tris buffer, 0.4 GTCATACTCATCCAGG.
mM MgCl2, 0.6 mM 2-mercaptoethanol (Boehringer Mannheim), PCR reactions were carried out in a Stratagene Robocycler using
0.5% Tween 20 (Bio-Rad) and 0.5% BSA (Sigma). Cells were incu- the following conditions: 35 cycles of 1 min at 948C, 1 min at 658C,
bated in the dark for 20 min prior to washing in PBS. 1 min at 728C. In the case of the Ptc primer pair, the annealing
Annexin-V staining was carried out using an Annexin-V-FITC apo- temperature was 608C.
ptosis detection kit (Pharmingen), according to manufacturer's in- In the experiment shown in Figures 1B and 7C, the quantity of
structions. Prior to Annexin-V staining, cells were stained with CD4PE each cDNA loaded on the gel was normalized relative to HPRT
and CD8aTRICOLOR as described. Propidium iodide (PI) staining of cells expression.
permeabalized in 0.1%Triton X-100 in PBS, was carried out ac-
cording to the manufacturer's instructions using a Pharmingen apo-
In Situ Hybridizationptosis detection kit. Data were acquired on a linear scale using a
In situ hybridizations were performed on paraformaldehyde-fixed,doublet discrimination module on the Facscan.
paraffin-embedded histological sections, as described (Wilkinson et
al., 1987). Briefly, 7 mm sections were cleared, rehydrated, digested
with proteinase K, acetylated, and hybridized with 33P-labeled RNAHistology and Immunofluorescence
Cryosections (7 mm) were air dried for 2 hr at room temperature and probes overnight. After high-stringency posthybridization washes,
slides were dipped in photo emulsion and incubated in the dark forfixed in acetone for 10 min. Nonspecific binding of antibodies was
blocked by incubation with diluted donkey serum (Santa Cruz Bio- 35 days at 48C. After developing, slides were counterstained with
hematoxylin and imaged using dark-field illumination. Sense andtechnology) and avidin-biotin (Vector Laboratories). The sections
were then sequentially incubated with anti-Shh or anti-Ihh antibod- antisense probes used were as follows: shh and ihh (Echelard et
al., 1993), smo (Stone et al., 1996), ptc-2 (Goodrich et al., 1996),ies (Santa Cruz Biotechnology), biotinylated donkey anti-goat IgG
(Jackson ImmunoResearch Laboratories), Texas red±conjugated gli-1, and gli-2 (Hui et al., 1994).
Hedgehog Regulates Early Thymocyte Development
197
PCR Analysis of TCRb Rearrangements A.M. (1999). Cell fate decisions in early T cell development: regula-
tion by cytokine receptors and the pre-TCR. Semin. Immunol. 11,Db to Jb rearrangements were analyzed in genomic DNA by a PCR
assay (Gaertner et al., 1999). Genomic DNA was isolated from sorted 23±37.
DN thymocytes using QIAgen DNeasy Tissue kit according to manu- Hammerschmidt, M., Brook, A., and McMahon, A. (1997). The world
facturer's instructions. The upstream primer used was located im- according to Hedgehog. Trends Genet. 13, 14±21.
mediately 59 of Db2, GTAGGCACCTGTGGGGAAGAAACT, and the Hebrok, M., Kim, S.K., and Melton, D.A. (1998). Notochord repres-
downstream primer was positioned 39 of Jb2.7, TGAGAGCTGTCTC sion of endodermal Sonic hedgehog permits pancreas development.
CTACTATCGATT. PCR reactions containing 100 ng genomic DNA Genes Dev. 12, 1705±1713.
template were carried out as previously described (Crompton et al.,
Hoffman, E.S., Passoni, L., Crompton, T., Leu, T.M.J., Schatz, D.G.,1997). Reactions were run on a Stratagene Robocycler as follows:
Koff, A., Owen, M.J., and Hayday, A.C. (1996). Productive T-cell3 min at 948C; 32 cycles of 45 s at 948C, 90 s at 658C, and 150 s at
receptor b-chain gene rearrangement: coincident regulation of cell728 C; and, finally, 10 min at 728C. DNA products were resolved on
cycle and clonality during development in vivo. Genes Dev. 10,a 1% agarose gel.
948±962.
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